2.04
price up icon2.51%   0.05
after-market Handel nachbörslich: 2.04
loading
Schlusskurs vom Vortag:
$1.99
Offen:
$2
24-Stunden-Volumen:
160.63K
Relative Volume:
0.62
Marktkapitalisierung:
$5.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.0381
EPS:
-53.609
Netto-Cashflow:
$-12.17M
1W Leistung:
+13.33%
1M Leistung:
+54.55%
6M Leistung:
-82.14%
1J Leistung:
-92.59%
1-Tages-Spanne:
Value
$1.86
$2.0442
1-Wochen-Bereich:
Value
$1.72
$2.09
52-Wochen-Spanne:
Value
$1.10
$43.69

Gri Bio Inc Stock (GRI) Company Profile

Name
Firmenname
Gri Bio Inc
Name
Telefon
(619) 400-1171
Name
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRI's Discussions on Twitter

Vergleichen Sie GRI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GRI
Gri Bio Inc
2.04 4.49M 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-09 Eingeleitet H.C. Wainwright Buy

Gri Bio Inc Aktie (GRI) Neueste Nachrichten

pulisher
12:23 PM

What analysts say about GRI Bio Inc. stockConsistent high-performance stocks - jammulinksnews.com

12:23 PM
pulisher
Jul 22, 2025

GRI Bio Inc. Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives GRI Bio Inc. stock priceOver 200% growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

GRI Bio Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

GRI Bio CEO Unveils Strategic Vision for Revolutionary NKT Cell Platform in Exclusive Interview - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Is GRI Bio Inc. a good long term investmentOver 200% growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - The Globe and Mail

Jul 20, 2025
pulisher
Jul 18, 2025

JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Knoxville News Sentinel

Jul 18, 2025
pulisher
Jul 17, 2025

AI in Retail and Consumer Goods5x Profit Potential - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

COLX(colossuscoinxt) Price TodayFast Growing Stocks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes GRI Bio Inc. stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How GRI Bio Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Eli Lilly and Company stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why GRI Bio Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

GRI Bio stock holds Buy rating at H.C. Wainwright as Phase 2a trial completes enrollment - Investing.com

Jul 02, 2025
pulisher
Jul 01, 2025

GRI Bio, Inc. Completes Patient Enrollment in Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis, Interim Results Show Safety and Tolerability - Nasdaq

Jul 01, 2025
pulisher
Jul 01, 2025

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”) - GlobeNewswire

Jul 01, 2025
pulisher
Jun 30, 2025

GRI Bio's GRI-0621: A Breakthrough in IPF with Near-Term Catalysts and a Growing Market - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

GRI Bio approves reverse stock split, stockholders vote in favor - MSN

Jun 27, 2025
pulisher
Jun 26, 2025

GRI Bio, Inc. Reports Positive 6-Week Interim Safety Results from its Ongoing Phase 2a Study Evaluating GRI-0621 for Treatment of Idiopathic Pulmonary Fibrosis - MarketScreener

Jun 26, 2025
pulisher
Jun 14, 2025

Q2 Earnings Estimate for GRI Bio Issued By HC Wainwright - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Kalkine : GRI Bio Advancing in the Nasdaq Composite Healthcare Space - Kalkine Media

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio (NASDAQ:GRI) Receives “Buy” Rating from HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

HC Wainwright Reiterates Buy Rating for GRI Bio (NASDAQ:GRI) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio’s (GRI) Buy Rating Reiterated at HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio (NASDAQ:GRI) Given “Buy” Rating at HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio (NASDAQ:GRI) Earns Buy Rating from HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio’s (GRI) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews

Jun 12, 2025
pulisher
Jun 11, 2025

# H.C. Wainwright REITERATES Buy rating on GRI Bio stock By Investing.com - Investing.com India

Jun 11, 2025
pulisher
Jun 11, 2025

# H.C. Wainwright REITERATES Buy rating on GRI Bio stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

GRI Stock Maintains Buy Rating and $10 Price Target | GRI Stock News - GuruFocus

Jun 11, 2025

Finanzdaten der Gri Bio Inc-Aktie (GRI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):